{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:37:27Z","timestamp":1793777847568,"version":"4.6.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["2019\u2014SRC 017"],"award-info":[{"award-number":["2019\u2014SRC 017"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["2019\u2014SRC 017"],"award-info":[{"award-number":["2019\u2014SRC 017"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008394","name":"Natur og Univers, Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["9040-00106B"],"award-info":[{"award-number":["9040-00106B"]}],"id":[{"id":"10.13039\/100008394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF19OC0056411"],"award-info":[{"award-number":["NNF19OC0056411"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-53329-8","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T04:03:06Z","timestamp":1729051386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Macrolide resistance through uL4 and uL22 ribosomal mutations in Pseudomonas aeruginosa"],"prefix":"10.1038","volume":"15","author":[{"given":"Lise","family":"Goltermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8281-7900","authenticated-orcid":false,"given":"Pablo","family":"Laborda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oihane","family":"Irazoqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Pogrebnyakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0642-2398","authenticated-orcid":false,"given":"Maria Pals","family":"Bendixen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Molin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0268-3717","authenticated-orcid":false,"given":"Helle Krogh","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6705-3989","authenticated-orcid":false,"given":"Ruggero","family":"La Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"key":"53329_CR1","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.tibs.2018.06.011","volume":"43","author":"N V\u00e1zquez-Laslop","year":"2018","unstructured":"V\u00e1zquez-Laslop, N. & Mankin, A. S. How Macrolide Antibiotics Work. Trends Biochem Sci. 43, 668\u2013684 (2018).","journal-title":"Trends Biochem Sci."},{"key":"53329_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24674-9","volume":"12","author":"B Beckert","year":"2021","unstructured":"Beckert, B. et al. Structural and mechanistic basis for translation inhibition by macrolide and ketolide antibiotics. Nat. Commun. 12, 4466 (2021).","journal-title":"Nat. Commun."},{"key":"53329_CR3","doi-asserted-by":"publisher","first-page":"5862","DOI":"10.1128\/JB.00632-08","volume":"190","author":"MG Lawrence","year":"2008","unstructured":"Lawrence, M. G., Lindahl, L. & Zengel, J. M. Effects on translation pausing of alterations in protein and RNA components of the ribosome exit tunnel. J. Bacteriol. 190, 5862\u20135869 (2008).","journal-title":"J. Bacteriol."},{"key":"53329_CR4","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.1128\/AAC.01230-07","volume":"52","author":"ME Skindersoe","year":"2008","unstructured":"Skindersoe, M. E. et al. Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 52, 3648\u20133663 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"key":"53329_CR5","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1128\/AAC.01011-06","volume":"51","author":"N Hoffmann","year":"2007","unstructured":"Hoffmann, N. et al. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-\/-) mice. Antimicrob. Agents Chemother. 51, 3677\u20133687 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"53329_CR6","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1128\/AAC.00613-07","volume":"51","author":"T K\u00f6hler","year":"2007","unstructured":"K\u00f6hler, T., Dumas, J.-L. & Van Delden, C. Ribosome protection prevents azithromycin-mediated quorum-sensing modulation and stationary-phase killing of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 51, 4243\u20134248 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"53329_CR7","doi-asserted-by":"publisher","first-page":"102095","DOI":"10.1016\/j.pupt.2021.102095","volume":"71","author":"J Pollock","year":"2021","unstructured":"Pollock, J. & Chalmers, J. D. The immunomodulatory effects of macrolide antibiotics in respiratory disease. Pulm. Pharm. Ther. 71, 102095 (2021).","journal-title":"Pulm. Pharm. Ther."},{"key":"53329_CR8","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1128\/CMR.00078-09","volume":"23","author":"S Kanoh","year":"2010","unstructured":"Kanoh, S. & Rubin, B. K. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin. Microbiol Rev. 23, 590\u2013615 (2010).","journal-title":"Clin. Microbiol Rev."},{"key":"53329_CR9","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/thoraxjnl-2019-213929","volume":"75","author":"D Smith","year":"2020","unstructured":"Smith, D. et al. British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease. Thorax 75, 370\u2013404 (2020).","journal-title":"Thorax"},{"key":"53329_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S2213-2600(20)30058-8","volume":"8","author":"HE Kobbernagel","year":"2020","unstructured":"Kobbernagel, H. E. et al. Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial. Lancet Respir. Med. 8, 493\u2013505 (2020).","journal-title":"Lancet Respir. Med."},{"key":"53329_CR11","doi-asserted-by":"crossref","unstructured":"Agust\u00ed, A. et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Eur. Respir. J. 61, 2300239 (2023).","DOI":"10.1183\/13993003.00239-2023"},{"key":"53329_CR12","doi-asserted-by":"crossref","unstructured":"Matuschek, E., Brown, D. F. J. & Kahlmeter, G. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clinical Microbiol. Infection 20, O255\u2013O266 (2014).","DOI":"10.1111\/1469-0691.12373"},{"key":"53329_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1183\/13993003.00689-2017","volume":"49","author":"JD Chalmers","year":"2017","unstructured":"Chalmers, J. D. Macrolide resistance in Pseudomonas aeruginosa: implications for practice. Eur. Respir. J. 49, 16\u201318 (2017).","journal-title":"Eur. Respir. J."},{"key":"53329_CR14","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.cmi.2022.08.003","volume":"28","author":"L Goltermann","year":"2022","unstructured":"Goltermann, L., Andersen, K. L., Johansen, H. K., Molin, S. & La Rosa, R. Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance. Clin. Microbiol. Infect. 28, 1594\u20131601 (2022).","journal-title":"Clin. Microbiol. Infect."},{"key":"53329_CR15","doi-asserted-by":"crossref","unstructured":"Laborda, P. et al. Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance. Nat. Commun. 15, 2584 (2024).","DOI":"10.1038\/s41467-024-46938-w"},{"key":"53329_CR16","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/cid\/cis473","volume":"55","author":"JM Buyck","year":"2012","unstructured":"Buyck, J. M. et al. Increased Susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability. Clin. Infect. Dis. 55, 534\u2013542 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"53329_CR17","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.str.2017.06.004","volume":"25","author":"I Wekselman","year":"2017","unstructured":"Wekselman, I. et al. The Ribosomal Protein uL22 Modulates the Shape of the Protein Exit Tunnel. Structure 25, 1233\u20131241.e3 (2017).","journal-title":"Structure"},{"key":"53329_CR18","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1006\/jmbi.1999.2839","volume":"289","author":"ST Gregory","year":"1999","unstructured":"Gregory, S. T. & Dahlberg, A. E. Erythromycin resistance mutations in ribosomal proteins L22 and L4 perturb the higher order structure of 23 S ribosomal RNA. J. Mol. Biol. 289, 827\u2013834 (1999).","journal-title":"J. Mol. Biol."},{"key":"53329_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/BF00333665","volume":"127","author":"HG Wittmann","year":"1973","unstructured":"Wittmann, H. G. et al. Biochemical and genetic studies on two different types of erythromycin resistant mutants of Escherichia coli with altered ribosomal proteins. Mol. Gen. Genet. 127, 175\u2013189 (1973).","journal-title":"Mol. Gen. Genet."},{"key":"53329_CR20","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1128\/AAC.00630-12","volume":"56","author":"RL Marvig","year":"2012","unstructured":"Marvig, R. L. et al. Mutations in 23S rRNA confer resistance against azithromycin in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 56, 4519\u20134521 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"53329_CR21","doi-asserted-by":"crossref","unstructured":"Mustafa, M.-H. et al. Acquired resistance to macrolides in Pseudomonas aeruginosa from cystic fibrosis patients. Eur. Respir. J. 49, 1601847 (2017).","DOI":"10.1183\/13993003.01847-2016"},{"key":"53329_CR22","doi-asserted-by":"publisher","first-page":"15379","DOI":"10.1073\/pnas.1410356111","volume":"111","author":"AR Davis","year":"2014","unstructured":"Davis, A. R., Gohara, D. W. & Yap, M.-N. F. Sequence selectivity of macrolide-induced translational attenuation. Proc. Natl. Acad. Sci. USA 111, 15379\u201315384 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"53329_CR23","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1128\/JB.00211-13","volume":"195","author":"M-NF Yap","year":"2013","unstructured":"Yap, M.-N. F. & Bernstein, H. D. Mutations in the Escherichia coli ribosomal protein L22 selectively suppress the expression of a secreted bacterial virulence factor. J. Bacteriol. 195, 2991\u20132999 (2013).","journal-title":"J. Bacteriol."},{"key":"53329_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.isci.2018.07.024","volume":"6","author":"W Chen","year":"2018","unstructured":"Chen, W. et al. CRISPR\/Cas9-based genome editing in Pseudomonas aeruginosa and cytidine deaminase-mediated base editing in Pseudomonas species. iScience 6, 222\u2013231 (2018).","journal-title":"iScience"},{"key":"53329_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23451-y","volume":"12","author":"R La Rosa","year":"2021","unstructured":"La Rosa, R., Rossi, E., Feist, A. M., Johansen, H. K. & Molin, S. Compensatory evolution of Pseudomonas aeruginosa\u2019s slow growth phenotype suggests mechanisms of adaptation in cystic fibrosis. Nat. Commun. 12, 3186 (2021).","journal-title":"Nat. Commun."},{"key":"53329_CR26","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1128\/AAC.50.5.1680-1688.2006","volume":"50","author":"Y Nalca","year":"2006","unstructured":"Nalca, Y. et al. Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimicrob. Agents Chemother. 50, 1680\u20131688 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"53329_CR27","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1111\/j.1365-2958.2007.05975.x","volume":"66","author":"S Zaman","year":"2007","unstructured":"Zaman, S., Fitzpatrick, M., Lindahl, L. & Zengel, J. Novel mutations in ribosomal proteins L4 and L22 that confer erythromycin resistance in Escherichia coli. Mol. Microbiol. 66, 1039\u20131050 (2007).","journal-title":"Mol. Microbiol."},{"key":"53329_CR28","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1093\/nar\/gkw493","volume":"44","author":"MG Lawrence","year":"2016","unstructured":"Lawrence, M. G. et al. The extended loops of ribosomal proteins uL4 and uL22 of Escherichia coli contribute to ribosome assembly and protein translation. Nucleic Acids Res. 44, 5798\u20135810 (2016).","journal-title":"Nucleic Acids Res."},{"key":"53329_CR29","doi-asserted-by":"crossref","unstructured":"Pedersen, B. H. et al. Metabolic specialization drives reduced pathogenicity in Pseudomonas aeruginosa isolates from cystic fibrosis patients. PLoS Biol. 22, e3002781 (2024).","DOI":"10.1371\/journal.pbio.3002781"},{"key":"53329_CR30","doi-asserted-by":"publisher","first-page":"126719","DOI":"10.1016\/j.micres.2021.126719","volume":"246","author":"G Horna","year":"2021","unstructured":"Horna, G. & Ruiz, J. Type 3 secretion system of Pseudomonas aeruginosa. Microbiol Res. 246, 126719 (2021).","journal-title":"Microbiol Res."},{"key":"53329_CR31","doi-asserted-by":"crossref","unstructured":"Murray, C. J. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet 6736, 629\u2013655 (2022).","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"53329_CR32","first-page":"1","volume":"3099","author":"T Bjarnsholt","year":"2021","unstructured":"Bjarnsholt, T. et al. The importance of understanding the infectious microenvironment. Lancet Infect. Dis. 3099, 1\u20135 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"53329_CR33","doi-asserted-by":"crossref","unstructured":"Van den Bossche, S., De Broe, E., Coenye, T., Van Braeckel, E. & Crabb\u00e9, A. The cystic fibrosis lung microenvironment alters antibiotic activity: Causes and effects. European Respiratory Rev. 30, 210055 (2021).","DOI":"10.1183\/16000617.0055-2021"},{"key":"53329_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/ng.3148","volume":"47","author":"RL Marvig","year":"2015","unstructured":"Marvig, R. L., Sommer, L. M., Molin, S. & Johansen, H. K. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat. Genet. 47, 57\u201364 (2015).","journal-title":"Nat. Genet."},{"key":"53329_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08504-7","volume":"10","author":"JA Bartell","year":"2019","unstructured":"Bartell, J. A. et al. Evolutionary highways to persistent bacterial infection. Nat. Commun. 10, 629 (2019).","journal-title":"Nat. Commun."},{"key":"53329_CR36","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/antibiotics11030419","volume":"11","author":"R La Rosa","year":"2022","unstructured":"La Rosa, R., Johansen, H. K. & Molin, S. Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution. Antibiotics 11, 419 (2022).","journal-title":"Antibiotics"},{"key":"53329_CR37","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41579-020-00477-5","volume":"19","author":"E Rossi","year":"2021","unstructured":"Rossi, E. et al. Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis. Nat. Rev. Microbiol. 19, 331\u2013342 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"53329_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41392-022-01056-1","volume":"7","author":"S Qin","year":"2022","unstructured":"Qin, S. et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct. Target Ther. 7, 199 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"53329_CR39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1128\/MMBR.05007-11","volume":"76","author":"P Nadal Jimenez","year":"2012","unstructured":"Nadal Jimenez, P. et al. The Multiple Signaling Systems Regulating Virulence in Pseudomonas aeruginosa. Microbiol. Mol. Biol. Rev. 76, 46\u201365 (2012).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"53329_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2016.184","volume":"2","author":"UN Broder","year":"2016","unstructured":"Broder, U. N. et al. LadS is a calcium-responsive kinase that induces acute-to-chronic virulence switch in Pseudomonas aeruginosa. Nat. Microbiol. 2, 16184 (2016).","journal-title":"Nat. Microbiol."},{"key":"53329_CR41","doi-asserted-by":"publisher","first-page":"16411","DOI":"10.1074\/jbc.RA119.012102","volume":"295","author":"EA Maunders","year":"2020","unstructured":"Maunders, E. A., Triniman, R. C., Western, J., Rahman, T. & Welch, M. Global reprogramming of virulence and antibiotic resistance in pseudomonas aeruginosa by a single nucleotide polymorphism in elongation factor, FusA1. J. Biol. Chem. 295, 16411\u201316426 (2020).","journal-title":"J. Biol. Chem."},{"key":"53329_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.1365-2958.1999.01142.x","volume":"31","author":"J Bj\u00f6rkman","year":"1999","unstructured":"Bj\u00f6rkman, J., Samuelsson, P., Andersson, D. I. & Hughes, D. Novel ribosomal mutations affecting translational accuracy, antibiotic resistance and virulence of Salmonella typhimurium. Mol. Microbiol 31, 53\u201358 (1999).","journal-title":"Mol. Microbiol"},{"key":"53329_CR43","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1128\/AAC.00709-13","volume":"57","author":"C Chen","year":"2013","unstructured":"Chen, C. et al. Restrictive streptomycin resistance mutations decrease the formation of attaching and effacing lesions in escherichia coli O157:H7 strains. Antimicrob. Agents Chemother. 57, 4260\u20134266 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"53329_CR44","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/1574-6976.12083","volume":"38","author":"AL Starosta","year":"2014","unstructured":"Starosta, A. L., Lassak, J., Jung, K. & Wilson, D. N. The bacterial translation stress response. FEMS Microbiol Rev. 38, 1172\u20131201 (2014).","journal-title":"FEMS Microbiol Rev."},{"key":"53329_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-36863-1","volume":"13","author":"T Leach","year":"2023","unstructured":"Leach, T. et al. Development of a novel air\u2013liquid interface airway tissue equivalent model for in vitro respiratory modeling studies. Sci. Rep. 13, 1\u201315 (2023).","journal-title":"Sci. Rep."},{"key":"53329_CR46","doi-asserted-by":"publisher","unstructured":"Tang, M. et al. Evaluating Bacterial Pathogenesis Using a Model of Human Airway Organoids Infected with Pseudomonas aeruginosa Biofilms. Microbiol. Spectr. https:\/\/doi.org\/10.1128\/spectrum.02408-22 (2022).","DOI":"10.1128\/spectrum.02408-22"},{"key":"53329_CR47","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.cmi.2022.09.010","volume":"28","author":"L Goltermann","year":"2022","unstructured":"Goltermann, L., Johansen, H. K., Molin, S. & La Rosa, R. Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance: author\u2019s response. Clin. Microbiol. Infect. 28, 1667\u20131668 (2022).","journal-title":"Clin. Microbiol. Infect."},{"key":"53329_CR48","doi-asserted-by":"crossref","unstructured":"Southern, K. W., Solis-Moya, A., Kurz, D. & Smith, S. Macrolide antibiotics (including azithromycin) for cystic fibrosis. Cochrane Database of Sys. Rev.2024, CD002203 (2024).","DOI":"10.1002\/14651858.CD002203.pub5"},{"key":"53329_CR49","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/jac\/dkl014","volume":"57","author":"SJ Phaff","year":"2006","unstructured":"Phaff, S. J., Tiddens, H. A. W. M., Verbrugh, H. A. & Ott, A. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis. J. Antimicrobial Chemother. 57, 741\u2013746 (2006).","journal-title":"J. Antimicrobial Chemother."},{"key":"53329_CR50","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jcf.2008.09.001","volume":"8","author":"CR Hansen","year":"2009","unstructured":"Hansen, C. R., Pressler, T., Hoiby, N. & Johansen, H. K. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients. J. Cyst. Fibros. 8, 58\u201362 (2009).","journal-title":"J. Cyst. Fibros."},{"key":"53329_CR51","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/35023079","volume":"406","author":"CK Stover","year":"2000","unstructured":"Stover, C. K. et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406, 959\u2013964 (2000).","journal-title":"Nature"},{"key":"53329_CR52","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1021\/acssynbio.5b00113","volume":"4","author":"AM Cavaleiro","year":"2015","unstructured":"Cavaleiro, A. M., Kim, S. H., Sepp\u00e4l\u00e4, S., Nielsen, M. T. & N\u00f8rholm, M. H. H. Accurate DNA assembly and genome engineering with optimized uracil excision cloning. ACS Synth. Biol. 4, 1042\u20131046 (2015).","journal-title":"ACS Synth. Biol."},{"key":"53329_CR53","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.mimet.2005.06.001","volume":"64","author":"KH Choi","year":"2006","unstructured":"Choi, K. H., Kumar, A. & Schweizer, H. P. A 10-min method for preparation of highly electrocompetent Pseudomonas aeruginosa cells: Application for DNA fragment transfer between chromosomes and plasmid transformation. J. Microbiol. Methods 64, 391\u2013397 (2006).","journal-title":"J. Microbiol. Methods"},{"key":"53329_CR54","doi-asserted-by":"publisher","first-page":"ix","DOI":"10.1046\/j.1469-0691.2003.00790.x","volume":"9","author":"EUCAST.","year":"2003","unstructured":"EUCAST. Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin. Microbiol. Infect. 9, ix\u2013xv (2003).","journal-title":"Clin. Microbiol. Infect."},{"key":"53329_CR55","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1465-9921-14-135","volume":"14","author":"MS Walters","year":"2013","unstructured":"Walters, M. S. et al. Generation of a human airway epithelium derived basal cell line with multipotent differentiation capacity. Respir. Res. 14, 135 (2013).","journal-title":"Respir. Res."},{"key":"53329_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).","journal-title":"Nucleic Acids Res."},{"key":"53329_CR57","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"53329_CR58","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"53329_CR59","doi-asserted-by":"publisher","unstructured":"Gabrielaite, M. & maanmi. MigleSur\/BacDist: First release of BacDist. https:\/\/doi.org\/10.5281\/zenodo.3667680 (2020).","DOI":"10.5281\/zenodo.3667680"},{"key":"53329_CR60","unstructured":"Hackl, S. et al. MUSIAL. https:\/\/github.com\/Integrative-Transcriptomics\/MUSIAL (2022)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53329-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53329-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53329-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T04:06:25Z","timestamp":1729051585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53329-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["53329"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-53329-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]},"assertion":[{"value":"11 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8906"}}